FBC
ASXC

Fairfield, Bush & Co’s Asensus Surgical, Inc. ASXC Stock Holding History

Fairfield, Bush & Co’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-150
Closed -$76 – 554
2023
Q2 		$76 Buy
+150
New +$90 ﹤0.01% 553
2022
Q3 		– Sell
-150
Closed – – 500
2022
Q2 		$0 Buy
+150
New +$67 ﹤0.01% 508

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fairfield, Bush & Co's ASXC Position: Q3 2023 in Review

Fairfield, Bush & Co sold out of Asensus Surgical, Inc. (ASXC) in Q3 2023, closing a stake of 150 shares — an estimated $76 sold.

Fairfield, Bush & Co first reported a position in ASXC in Q2 2022 and held it in 2 quarters. The position peaked at $76 in Q2 2023. 68 funds tracked by Wall St. Rank hold ASXC as of Q3 2023.

  • Fairfield, Bush & Co reported no remaining Asensus Surgical, Inc. position as of Q3 2023 after selling out during the quarter.
  • Fairfield, Bush & Co sold 150 Asensus Surgical, Inc. shares in Q3 2023, an estimated $76.
  • Fairfield, Bush & Co first reported a position in Asensus Surgical, Inc. in Q2 2022 and held it in 2 quarters.
  • Fairfield, Bush & Co's Asensus Surgical, Inc. position peaked at $76 in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2023.

Based on Fairfield, Bush & Co's 13F filing for Q3 2023, filed 15 Nov 2023.